ch.oddb.org 
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "R03D" (62)Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Aminophylline (R03DA05) 5 products WHO-DDD DrugBank.ca 
  IP  Aminophyllin Amino10 x 10 mlk.A.Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte
B
  IP  Escophyllin i.v.5 ampoule(s) à 10 ml3.358.05k.A.Injection solution: Theophyllinum 190 mgG. Streuli & Co. AGB / SO
  IP  Escophyllin i.v.10 ampoule(s) à 10 ml13.35k.A.Injection solution: Theophyllinum 190 mgG. Streuli & Co. AGB
  IP  Escophyllin i.v.50 ampoule(s) à 10 ml44.45k.A.Injection solution: Theophyllinum 190 mgG. Streuli & Co. AGB
  IPCI Phyllotemp Continus 22560 Tablet(s)12.7427.30k.A.Delayed release tablets: Theophyllinum Et Ethylendiaminum 225 mgMundipharma Medical
Company
B
Montelukast (R03DC03) 34 products WHO-DDD DrugBank.ca 
L IPCICMLukair 4 mg28 Tablet(s)16.2934.0010 %Chewing tablets: Montelukastum 4 mgOrganon GmbHB / SL / SO
L IPCICMLukair 4 mg98 Tablet(s)57.0977.9510 %Chewing tablets: Montelukastum 4 mgOrganon GmbHB / SL / SO
L IPCICMLukair 5 mg28 Tablet(s)16.2333.9010 %Chewing tablets: Montelukastum 5 mgOrganon GmbHB / SL / SO
L IPCICMLukair 5 mg98 Tablet(s)56.8977.7510 %Chewing tablets: Montelukastum 5 mgOrganon GmbHB / SL / SO
L IPCICMLukair 4 mg28 Sachet(s)17.5335.2510 %Granulate: Montelukastum 4 mgOrganon GmbHB / SL / SO
L IPCICMLukair 10 mg28 Tablet(s)16.2333.9510 %Coated tablets: Montelukastum 10 mgOrganon GmbHB / SL / SO
L IPCICMLukair 10 mg98 Tablet(s)56.8977.7510 %Coated tablets: Montelukastum 10 mgOrganon GmbHB / SL / SO
L IPCI Singulair28 Tablet(s)16.3034.0010 %Coated tablets: Montelukastum 10 mgOrganon GmbHB / SL / SO
L IPCI Singulair98 Tablet(s)56.8977.7510 %Coated tablets: Montelukastum 10 mgOrganon GmbHB / SL / SO
L IPCI Singulair 5 mg28 Tablet(s)16.3034.0010 %Kautabletten für Kinder: Montelukastum 5 mgOrganon GmbHB / SL / SO
L IPCI Singulair 5 mg98 Tablet(s)56.8977.7510 %Kautabletten für Kinder: Montelukastum 5 mgOrganon GmbHB / SL / SO
L IPCI Singulair 4 mg28 Tablet(s)16.2934.0010 %Kautabletten für Kleinkinder: Montelukastum 4 mgOrganon GmbHB / SL / SO
L IPCI Singulair 4 mg98 Tablet(s)56.8577.7010 %Kautabletten für Kleinkinder: Montelukastum 4 mgOrganon GmbHB / SL / SO
L IPCI Montelukast Sandoz 4 mg28 Tablet(s)13.8531.5010 %Chewing tablets: Montelukastum 4 mgSandoz
Pharmaceuticals AG
B / SL / SG
L IPCI Montelukast Sandoz 4 mg98 Tablet(s)48.3669.0010 %Chewing tablets: Montelukastum 4 mgSandoz
Pharmaceuticals AG
B / SL / SG
L IPCI Montelukast Sandoz 5 mg28 Tablet(s)13.8531.5010 %Chewing tablets: Montelukastum 5 mgSandoz
Pharmaceuticals AG
B / SL / SG
L IPCI Montelukast Sandoz 5 mg98 Tablet(s)48.3669.0010 %Chewing tablets: Montelukastum 5 mgSandoz
Pharmaceuticals AG
● B / SL / SG
L IPCI Montelukast Spirig HC 428 Tablet(s)13.8631.5010 %Chewing tablets: Montelukastum 4 mgSpirig HealthCare AGB / SL / SG
L IPCI Montelukast Spirig HC 498 Tablet(s)48.3669.0010 %Chewing tablets: Montelukastum 4 mgSpirig HealthCare AGB / SL / SG
L IPCI Montelukast Spirig HC 528 Tablet(s)13.8631.5010 %Chewing tablets: Montelukastum 5 mgSpirig HealthCare AGB / SL / SG
L IPCI Montelukast Spirig HC 598 Tablet(s)48.3669.0010 %Chewing tablets: Montelukastum 5 mgSpirig HealthCare AGB / SL / SG
L IPCI Montelukast-Mepha 4 mg28 Tablet(s)13.8531.5010 %Chewing tablets: Montelukastum 4 mgMepha Pharma AGB / SL / SG
L IPCI Montelukast-Mepha 4 mg98 Tablet(s)48.3669.0010 %Chewing tablets: Montelukastum 4 mgMepha Pharma AGB / SL / SG
L IPCI Montelukast-Mepha 5 mg28 Tablet(s)13.8531.5010 %Chewing tablets: Montelukastum 5 mgMepha Pharma AGB / SL / SG
L IPCI Montelukast-Mepha 5 mg98 Tablet(s)48.3669.0010 %Chewing tablets: Montelukastum 5 mgMepha Pharma AGB / SL / SG
L IPCI Montelukast-Mepha 428 piece(s)13.8531.5010 %Granulate: Montelukastum 4 mgMepha Pharma AGB / SL / SG
L IPCI Montelukast Sandoz 10 mg28 Tablet(s)13.8531.5010 %Coated tablets: Montelukastum 10 mgSandoz
Pharmaceuticals AG
B / SL / SG
L IPCI Montelukast Sandoz 10 mg98 Tablet(s)48.3669.0010 %Coated tablets: Montelukastum 10 mgSandoz
Pharmaceuticals AG
B / SL / SG
L IPCI Montelukast Spirig HC 103014.8532.5010 %Coated tablets: Montelukastum 10 mgSpirig HealthCare AGB / SL / SG
L IPCI Montelukast Spirig HC 1010049.3570.0510 %Coated tablets: Montelukastum 10 mgSpirig HealthCare AG● B / SL / SG
L IPCI Montelukast-Mepha 10 mg28 Tablet(s)13.8531.5010 %Coated tablets: Montelukastum 10 mgMepha Pharma AGB / SL / SG
L IPCI Montelukast-Mepha 10 mg98 Tablet(s)48.3669.0010 %Coated tablets: Montelukastum 10 mgMepha Pharma AGB / SL / SG
  IPCI Singulair 4 mg28 Sachet(s)19.9637.95k.A.Granulate: Montelukastum 4 mgOrganon GmbHB
L IPCI Montelukast Sandoz 428 Sachet(s)13.8531.5010 %Granulate: Montelukastum 4 mgSandoz
Pharmaceuticals AG
B / SL / SG
Omalizumab (R03DX05) 12 products WHO-DDD DrugBank.ca 
L IPCI Xolair 75 mg/0.5 ml 166.63194.9010 %Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG
B / SL / SO
L IPCI Xolair 75 mg/0.5 ml 166.63194.9010 %Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG
B / SL / SO
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injection solution in prefilled syringe: Omalizumabum 150mg / 1mlNovartis Pharma
Schweiz AG
B / SL / SO
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injection solution in prefilled syringe: Omalizumabum 150mg / 1mlNovartis Pharma
Schweiz AG
B / SL / SO
LSIPIPCI Xolair 150 mgampoule(s)333.25373.3510 %Lyophilisate and solvent: Omalizumabum 150 mgNovartis Pharma
Schweiz AG
B / SL / SO
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injektionslösung in einem Fertigpen: Omalizumabum 150 mg/mlNovartis Pharma
Schweiz AG
B / SL / SO
L IPCI Omlyclo 75 mg/0.5 ml 122.15149.2510 %solution injectable en seringue préremplie: Omalizumabum 75mg / 0.5mliQone Healthcare
Switzerland SA
B / SL / SG
L IPCI Omlyclo 150 mg/1 ml 244.29282.1010 %solution injectable en seringue préremplie: Omalizumabum 150 mg/mliQone Healthcare
Switzerland SA
B / SL / SG
L IPCI Xolair 300 mg/2 ml 666.50741.2510 %Injection solution in prefilled syringe: Omalizumabum 300mg / 2mlNovartis Pharma
Schweiz AG
B / SL
L IPCI Xolair 300 mg/2.0 ml 666.50741.2510 %Injektionslösung in einem Fertigpen: Omalizumabum 300mg / 2mlNovartis Pharma
Schweiz AG
B / SL
 SIPIPCI Xolair 75 mgampoule(s)k.A.Lyophilisate and solvent: Omalizumabum 75 mgNovartis Pharma
Schweiz AG
B
  IPCI Xolair 75 mg/0.5 ml k.A.Injektionslösung in einem Fertigpen: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG
B
Roflumilast (R03DX07) 1 products WHO-DDD DrugBank.ca 
  IPCI Daxas 500 ug30 Tablet(s)54.0675.2010 %Coated tablets: Roflumilastum 500 µgAstraZeneca AGB / SL
Reslizumab (R03DX08) 2 products WHO-DDD  
L IP  Cinqaero 100 mg/10 mL 510.32571.4010 %Concentrate for infusion: Reslizumabum 100mg / 10mlTeva Pharma AGB / SL
L IP  Cinqaero 25 mg/2,5 mL 127.59155.2010 %Concentrate for infusion: Reslizumabum 25mg / 2.5mlTeva Pharma AGB / SL
Mepolizumab (R03DX09) 2 products WHO-DDD  
L IPCI Nucala 100 mg/mL 976.631078.5510 %Injektionslösung im Fertigpen: Mepolizumabum 100mg / 1mlGlaxoSmithKline AGB / SL
L IPCI Nucala 100 mg/mL 976.631078.5510 %Injektionslösung in der Fertigspritze: Mepolizumabum 100mg / 1mlGlaxoSmithKline AGB / SL
Benralizumab (R03DX10) 2 products WHO-DDD  
L IPCI Fasenra 30 mg /1 ml 1929.052114.3510 %Injection solution in prefilled syringe: Benralizumabum 30 mg/mlAstraZeneca AGB / SL
L IPCI Fasenra Pen 30 mg /1 ml 1929.052114.3510 %lnjektionslösung: Benralizumabum 30 mg/mlAstraZeneca AGB / SL
Tezepelumab (R03DX11) 2 products WHO-DDD  
L IPCI Tezspire 995.241098.8010 %Injection solution in prefilled syringe: Tezepelumabum 210 mgAstraZeneca AGB / SL
L IPCI Tezspire 110 mg/ml 995.241098.8010 %Injektionslösung in einem Fertigpen: Tezepelumabum 210 mgAstraZeneca AGB / SL
(R03DZ) 2 products WHO-DDD  
   CIHRegenaplex Nr. 24c15 mlk.A.Tropfen zum Einnehmen: 10 Active AgentsRegena AGD
   CIHRegenaplex Nr. 24b15 mlk.A.Tropfen zum Einnehmen: 10 Active AgentsRegena AGD
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home